ChemoMetec A/S (CPH:CHEMM)

Denmark flag Denmark · Delayed Price · Currency is DKK
742.00
-7.50 (-1.00%)
At close: Dec 5, 2025
55.17%
Market Cap 12.91B
Revenue (ttm) 495.57M
Net Income (ttm) 186.41M
Shares Out 17.40M
EPS (ttm) 10.71
PE Ratio 69.28
Forward PE 49.91
Dividend 7.00 (0.93%)
Ex-Dividend Date Oct 10, 2025
Volume 21,897
Average Volume 28,089
Open 749.50
Previous Close 749.50
Day's Range 741.00 - 751.00
52-Week Range 367.00 - 804.00
Beta 1.59
RSI 47.77
Earnings Date Feb 4, 2026

About ChemoMetec

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 170
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol CHEMM
Full Company Profile

Financial Performance

In 2025, ChemoMetec's revenue was 495.57 million, an increase of 21.50% compared to the previous year's 407.87 million. Earnings were 186.41 million, an increase of 36.78%.

Financial Statements

News

Full Year 2025 Chemometec A/S Earnings Call Transcript

Full Year 2025 Chemometec A/S Earnings Call Transcript

4 weeks ago - GuruFocus

Half Year 2025 Chemometec A/S Earnings Call Transcript

Half Year 2025 Chemometec A/S Earnings Call Transcript

10 months ago - GuruFocus